Hoʻohui ʻia nā mea maʻi hanu
inoa huahana
HWTS-RT158A Puke Hoʻonaʻauao Hoʻohui ʻia (Fluorescence PCR)
Palapala
CE
Epidemiology
ʻO ka maʻi ʻo Corona Virus 2019, i kapa ʻia ʻo'COVID-19', e pili ana i ka maʻi pneumonia i hoʻokumu ʻia e ka maʻi 2019-nCoV. ʻO 2019-nCoV kahi coronavirus no ka β genus. ʻO COVID-19 kahi maʻi maʻi ʻeha hanu, a maʻalahi ka heluna kanaka. I kēia manawa, ʻo ke kumu o ka maʻi ka nui o nā maʻi i loaʻa i ka maʻi 2019-nCoV, a ʻo ka poʻe maʻi asymptomatic paha ke kumu o ka maʻi. Ma muli o ka noiʻi epidemiological o kēia manawa, ʻo ka manawa incubation he 1-14 mau lā, ʻo ka hapa nui he 3-7 mau lā. ʻO ke kuni, ka ʻū maloʻo a me ka luhi nā hōʻike nui. Ua loaʻa i kekahi mau maʻi nā hōʻailona e like me ka nasal congestion, runny ihu, ʻeha ʻāʻī, myalgia a me ka diarrhea, etc.
ʻO ka maʻi influenza, i ʻike nui ʻia ʻo "flu", he maʻi ʻeha ʻeha i hoʻokumu ʻia e ka maʻi maʻi influenza. He ma'i lele loa. Hoʻouna nui ʻia ia e ka ʻu ʻana a me ke kihe ʻana. He mea maʻamau i ka pūnāwai a me ka hoʻoilo. Hoʻokaʻawale ʻia nā maʻi maʻi influenza i ka influenza A (IFV A), influenza B (IFV B), a me ka Influenza C (IFV C) ʻekolu ʻano, aia nā mea āpau i ka maʻi maʻi sticky, ke kumu o ka maʻi o ke kanaka no ka maʻi maʻi influenza A a me B, ʻo ia ka mea maʻi RNA i hoʻokaʻawale ʻia. ʻO ka maʻi Influenza A he maʻi hanu nui, e like me H1N1, H3N2 a me nā ʻano subtype ʻē aʻe, hiki ke hoʻololi a maʻi i ka honua holoʻokoʻa. ʻO ka "Shift" e pili ana i ka hoʻololi ʻana o ka maʻi maʻi influenza A, ka hopena i ka puka ʻana mai o kahi maʻi hou "subtype". Ua māhele ʻia nā maʻi maʻi influenza B i ʻelua laina, ʻo Yamagata a me Victoria. ʻO ka maʻi Influenza B wale nō ka antigenic drift, a pale aku i ka nānā ʻana a me ka hoʻopau ʻana o ka ʻōnaehana pale kanaka ma o kona hoʻololi ʻana. Eia naʻe, ʻoi aku ka lohi o ka hoʻololi ʻana o ka maʻi maʻi influenza B ma mua o ka maʻi influenza A kanaka. Hiki i ka ma'i Influenza B ke ho'oulu i ka ma'i hanu kanaka a alaka'i i ka ma'i ahulau.
ʻO ka maʻi maʻi hanu hanu (RSV) he maʻi RNA, no ka ʻohana paramyxoviridae. Hoʻouna ʻia ia e nā kulu lewa a me ka pilina pili a ʻo ia ka pathogen nui o ka maʻi ʻeha haʻahaʻa o ka ʻōpū o nā pēpē. Hiki i nā kamaliʻi i loaʻa i ka RSV ke hoʻomohala i ka bronchiolitis koʻikoʻi a me ka maʻi pneumonia, pili i ka hānō i nā keiki. Loaʻa i nā pēpē nā hōʻailona koʻikoʻi, e like me ke kuni kiʻekiʻe, rhinitis, pharyngitis a me ka laryngitis, a laila bronchiolitis a me ka maʻi pneumonia. Hiki ke paʻakikī kekahi mau keiki maʻi me ka otitis media, pleurisy a me ka myocarditis, a me nā mea ʻē aʻe.
Kanal
FAM | SARS-CoV-2 |
VIC(HEX) | RSV |
CY5 | IFV A |
ROX | IFV B |
Quasar 705 | Hoomalu Kuloko |
Nā ʻāpana ʻenehana
Waihona | -18 ℃ |
Kau-ola | 12 mahina |
ʻAno Hoʻohālike | ʻOropharyngeal swab |
Ct | ≤38 |
LoD | 2019-nCoV: 300 kope/mL ʻO ka maʻi maʻi Influenza A/Maʻi maʻi influenza B/Maʻi hoʻomaʻamaʻa hanu: 500 Kopi/mL |
kikoo | a) Hōʻike nā hualoaʻa cross-reactivity ʻaʻohe hopena keʻa ma waena o ka kit a me ka coronavirus kanaka SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63, parainfluenza virus type 1, 2, 3, rhinovirus A, humanydia me ka maʻi pneumonia, humanydia enterovirus. B, C, D, ma'i ma'i epstein-barr, ma'i ma'i 'a'ai, ma'i cytomegalo kanaka, rotavirus, norovirus, ma'i parotitis, ma'i varicella-zoster, legionella, bordetella pertussis, haemophilus influenzae, staphylococcus aureus, streptococcus pneumoniae, streptococcus pyogenes, streptococcus pyogenes, tuberculosis, myococcus pyogenes. candida albicans, candida glabrata, pneumocystis jiroveci a me cryptococcus hānau hou a me ke kanaka genomic nucleic acid. b) Hiki ke hoʻopilikia: koho i ka mucin (60mg / mL), 10% (v / v) o ke koko a me ka phenylephrine (2mg / mL), oxymetazoline (2mg / mL), sodium chloride (me nā preservatives) (20mg / mL), beclomethasone (20mg / mL), dexanisg/mL (20mg/mL), dexamgolimethasone (2) triamcinolone acetonide (2mg/mL), budesonide (2mg/mL), mometasone (2mg/mL), fluticasone (2mg/mL), histamine hydrochloride (5mg/mL), alpha interferon (800IU/mL), zanamivir (20mg/mL), ribavirin (10mg/mL), ribavirin (10mg/mL) (1mg/mL), lopinavir (500mg/mL), ritonavir (60mg/mL), mupirocin (20mg/mL), azithromycin (1mg/mL), ceftriaxone (40μg/mL), meropenem (200mg/mL), levofloxacin (10μg/mL) a me ka ho'āʻo. Hōʻike nā hualoaʻa ʻaʻohe hopena hoʻopilikia i nā hopena hoʻāʻo o nā pathogens. |
Nā mea hana pili | BioRad CFX96 Pūnaehana PCR Manawa maoli Rotor-Gene Q 5plex HRM Platform Pūnaehana PCR manawa maoli |
